Disease | schizophrenia |
Symptom | C0543891|neuroleptic-induced tardive dyskinesia |
Sentences | 2 |
PubMedID- 22071797 | Objectives: to determine the effects of calcium-channel blocker drugs (diltiazem, nifedipine, nimodipine, verapamil) for treatment of neuroleptic-induced tardive dyskinesia in people with schizophrenia, schizoaffective disorder or other chronic mental illnesses. |
PubMedID- 25866243 | Objectives: to determine the effectiveness of pyridoxal 5 phosphate (vitamin b6 or pyridoxine or pyridoxal phosphate) in the treatment of neuroleptic-induced tardive dyskinesia among people with schizophrenia and other related psychotic disorders. |
Page: 1